Chongqing CAMAB Biotech

Chongqing CAMAB Biotech is a private Chinese biotechnology company focused on discovery of fully human therapeutic antibodies and related antibody-based biologics. The company's core asset is CAMouse, its proprietary transgenic human antibody mouse platform, which it uses to generate fully human antibodies and support early-stage antibody drug discovery for internal and partnered programs. Publicly visible intellectual property suggests activity in anti-GPC3 monoclonal antibodies, GPC3/CD3 bispecific antibodies, anti-VISTA antibodies, and humanized antibody-enabling nucleic acid and animal-model technologies. CAMAB appears to operate primarily as a discovery-stage platform biotech rather than a clinical-stage drug developer, with capabilities spanning antibody generation, experimental animal resources, and early biologics R&D services.